Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering

Липидные наночастицы превосходят электропорацию при конструировании CAR-T-клеток на основе мРНК
Ulrike Koehl, Sandy Tretbar, Stephan Fricke, Reni Kitte, Martin Rabel, Reka Geczy, Stella Park
2023-10-18

CAR T cell engineeringchimeric antigen receptorselectroporationlipid nanoparticlesmRNA delivery
Engineered T cells expressing chimeric antigen receptors (CARs) have been proven as efficacious therapies against selected hematological malignancies. However, the approved CAR T cell therapeutics strictly rely on viral transduction, a time- and cost-intensive procedure with possible safety issues. Therefore, the direct transfer of in vitro transcribed CAR-mRNA into T cells is pursued as a promising strategy for CAR T cell engineering. Electroporation (EP) is currently used as mRNA delivery method for the generation of CAR T cells in clinical trials but achieving only poor anti-tumor responses. Here, lipid nanoparticles (LNPs) were examined for ex vivo CAR-mRNA delivery and compared with EP. LNP-CAR T cells showed a significantly prolonged efficacy in vitro in comparison with EP-CAR T cells as a result of extended CAR-mRNA persistence and CAR expression, attributed to a different delivery mechanism with less cytotoxicity and slower CAR T cell proliferation. Moreover, CAR expression and in vitro functionality of mRNA-LNP-derived CAR T cells were comparable to stably transduced CAR T cells but were less exhausted. These results show that LNPs outperform EP and underline the great potential of mRNA-LNP delivery for ex vivo CAR T cell modification as next-generation transient approach for clinical studies.
1
CAR expression and in vitro functionality of LNP-derived CAR T cells were comparable to stably transduced CAR T cells, while exhaustion was reduced.
2
LNP delivery was associated with lower cytotoxicity and slower CAR T-cell proliferation than electroporation.
3
LNP-derived CAR T cells showed significantly longer in vitro efficacy than electroporated cells because of greater CAR-mRNA persistence and prolonged CAR expression.
4
Lipid nanoparticles enabled ex vivo delivery of CAR mRNA into T cells and outperformed electroporation in CAR T-cell engineering.
5
The findings support mRNA-LNP delivery as a promising transient, nonviral approach for clinical CAR T-cell modification.

ex vivo CAR T cells engineered by delivery of in vitro-transcribed CAR mRNA using lipid nanoparticles or electroporation

Comparative CAR-mRNA delivery performance, including CAR-mRNA persistence, CAR expression, anti-tumor efficacy, cytotoxicity, proliferation, functionality, and exhaustion

Publication Details
Publication Date
2023-10-18
Journal
Publisher
ISSN
Cited by
128
Access Type
Author Information
Authors
Ulrike Koehl
Sandy Tretbar
Stephan Fricke
Reni Kitte
Martin Rabel
Reka Geczy
Stella Park
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%